Screening for depression in children and adolescents in primary care or non-mental health settings: a systematic review update

• Published in: Systematic reviews Vol. 13; no. 1; pp. 48 - 15
• Main Authors: Beck, Andrew, Dryburgh, Nicole, Bennett, Alexandria, Shaver, Nicole, Esmaeilisaraji, Leila, Skidmore, Becky, Patten, Scott, Bragg, Heather, Colman, Ian, Goldfield, Gary S, Nicholls, Stuart Gordon, Pajer, Kathleen, Meeder, Robert, Vasa, Priya, Shea, Beverley J, Brouwers, Melissa, Little, Julian, Moher, David
• Format: Journal Article
• Language: English
• Published: England BioMed Central 31-01-2024; BMC
• Subjects: Adolescent; Antidepressants; Child; Child development; Child discipline; Children; Children & youth; Depression; Females; Medical screening; Mental depression; Mental disorders; Mental health; Patients; Primary care; Questionnaires; Screening; Systematic review; Systematic Review Update; Task forces; Teenagers; Working groups; Screening; Adolescent; Depression; Systematic review; Youth; Children; Child
• ISSN: 2046-4053; 2046-4053
• DOI: 10.1186/s13643-023-02447-3

The transition from childhood to adolescence is associated with an increase in rates of some psychiatric disorders, including major depressive disorder, a debilitating mood disorder. The aim of this systematic review is to update the evidence on the benefits and harms of screening for depression in primary care and non-mental health clinic settings among children and adolescents.
This review is an update of a previous systematic review, for which the last search was conducted in 2017. We searched Ovid MEDLINE® ALL, Embase Classic+Embase, PsycINFO, Cochrane Central Register of Controlled Trials, and CINAHL on November 4, 2019, and updated on February 19, 2021. If no randomized controlled trials were found, we planned to conduct an additional search for non-randomized trials with a comparator group. For non-randomized trials, we applied a non-randomized controlled trial filter and searched the same databases except for Cochrane Central Register of Controlled Trials from January 2015 to February 2021. We also conducted a targeted search of the gray literature for unpublished documents. Title and abstract, and full-text screening were completed independently by pairs of reviewers.
In this review update, we were unable to find any randomized controlled studies that satisfied our eligibility criteria and evaluated the potential benefits and harms of screening for depression in children and adolescents. Additionally, a search for non-randomized trials yielded no studies that met the inclusion criteria.
The findings of this review indicate a lack of available evidence regarding the potential benefits and harms of screening for depression in children and adolescents. This absence of evidence emphasizes the necessity for well-conducted clinical trials to evaluate the effectiveness of depression screening among children and adolescents in primary care and non-mental health clinic settings.
PROSPERO CRD42020150373 .